Pfizer (PFE): Director bought ~$28K
Scott Gottlieb, Director at Pfizer, bought ~$28K of Pfizer shares.
- ~$28K
- Approx. value · 1,000 sh @ $28.24
- 10K
- Holds after · shares reported
- Traded
- Oct 30, 2024
- Filed
- Oct 31, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 9, 2024CongressDisclosed sale of PFE — reported range $1,001 - $15,000
- Sep 12, 2024FDAFDA drug approval: Mektovi
- Sep 12, 2024FDAFDA drug approval: Braftovi
- Oct 11, 2024FDAFDA drug approval: Hympavzi
- Oct 15, 2024FDAFDA drug approval: Fragmin
- Oct 15, 2024CongressDisclosed sale of PFE — reported range $1,001 - $15,000
- Oct 21, 2024CongressDisclosed purchase of PFE — reported range $15,001 - $50,000
- Oct 30, 2024 · this disclosureInsiderDirector purchased ~$28K of PFE shares in the open market
What came next
- Dec 20, 2024FDAFDA drug approval: Braftovi
- Dec 20, 2024Layoff notice · Heights Union East, 2002 N. 6th Floor, TAMPA, FL, 33602Layoff notice filed in FL: 62 employees
- Jan 15, 2025CongressDisclosed partial sale of PFE — reported range $1,001 - $15,000
- Jan 24, 2025CongressDisclosed partial sale of PFE — reported range $1,001 - $15,000
- Jan 31, 2025FDAFDA drug approval: Paxlovid (Copackaged)
- Feb 13, 2025InsiderDirector purchased ~$499K of PFE shares in the open market
- Feb 21, 2025FDAFDA drug approval: Xeljanz
- Feb 21, 2025FDAFDA drug approval: Xeljanz XR
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Pfizer
OQRO holds no insider, Congress, fund or contract record for Pfizer dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PFE page.
Other recent filings by Scott Gottlieb, Director
- SEC Form 4 at Illumina, Inc. (ILMN)Feb 11, 2026
- SEC Form 4 at Illumina, Inc. (ILMN)Nov 5, 2025
- SEC Form 4 at Tempus AI (TEM)Apr 3, 2025
- SEC Form 4 at Tempus AI (TEM)Apr 3, 2025
- SEC Form 4 at Tempus AI (TEM)Apr 3, 2025
The full history of Scott Gottlieb, Director is on the profile page.
How this filing works
Explore the data
Other disclosures at Pfizer
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its PFE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
